The Company’s 2023 Stock Incentive Plan (“the Plan”) provides for the grant of various forms of stock-based compensation awards that may be settled in, or based upon the value of, the Company’s common stock. The maximum number of shares available for issuance under the Plan is 120,000 shares. The restricted stock has voting rights and rights to dividends, which are paid upon the vest date. For further information on the Plan, please refer to the Company’s 2025 Form 10-K.

As of December 31, 2025, the Company had nonvested restricted stock awards ("RSAs"), granted to non-employee directors, and restricted stock units ("RSUs"), granted to designated employees. During 2026, the Company awarded to designated employees additional RSUs that will vest in equal parts in 2027, 2028, and 2029. The Company also granted to directors additional RSAs that will vest in 2027.

The Company valued the RSAs and RSUs at the closing stock price on the grant date. The Company records expense over the associated vesting period. Stock based compensation expense charged against income was $63 and $125 for the three and six months ended June 30, 2026 and $51 and $94 for the three and six months ended June 30, 2025. As of June 30, 2026, compensation expense of $188 related to the nonvested RSAs and RSUs is expected to be recognized over the coming 12 months. A summary of changes in the Company’s nonvested RSAs and RSUs under the Plan for the six months ended June 30, 2026 follows:


	Shares			Weighted-Average Grant-Date Fair Value
Nonvested at January 1, 2026		9,584		$	28.85
Granted		6,937			37.25
Vested and released		(2,630	)		26.59
Forfeited		(1,835	)		33.11
Nonvested at June 30, 2026		12,056		$	33.53